Fresenius Medical Care (FMC), the world’s largest provider of dialysis products and services, will buy NxStage, a home dialysis device maker, for $2 billion. Fresenius Medical Care North America and NxStage both have corporate headquarters in the Boston area, while FMC parent company is based in Bad Homburg, Germany.
The NxStage System One is cleared by the FDA for home hemodialysis and home nocturnal hemodialysis. NxStage has also established a small number of dialysis clinics.
The NxStage transaction is the latest in “a wave of deals across the medical-device industry in which companies increasingly look to bolster product suites and gain more leverage to resist pricing pressure from hospitals,” Modern Healthcare wrote of the acquisition.
The deal give NxStage access to the resources of a larger company, and lets FMC further leverage its manufacturing, supply chain, and marketing competencies across the dialysis products, services, and care co-ordination businesses in a less labor- and capital-intensive care setting.
